Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia

Mežnar et al., NCT04355026, NCT04355026, Jul 2020
Estimated 90 patient bromhexine + HCQ late treatment RCT with results not reported over 6 years after estimated completion.
Bromhexine efficacy may vary depending on the degree of TMPRSS-dependent fusion for different variants1,2.
2 bromhexine RCTs have results missing long after expected3,4
The trials report an estimated total of 304 patients.
Study covers TMPRSS2 inhibitors, bromhexine, and HCQ.
Mežnar et al., 31 Jul 2020, Randomized Controlled Trial, this trial uses multiple treatments in the treatment arm (combined with HCQ) - results of individual treatments may vary, trial NCT04355026 (history).
Late treatment
is less effective